Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Sep
11
2024
 Petitions Filed to Add Several Chemicals to List of Taxable Substances; Comments Due November 4, 2024 Bergeson & Campbell, P.C.
Sep
11
2024
 This Week in 340B: September 3 – 9, 2024 McDermott Will & Emery
Sep
10
2024
 NIFA Announces $5.3 Million Investment in Biotechnology Risk Assessment Research Bergeson & Campbell, P.C.
Sep
10
2024
 FDA Rejects MDMA Treatment for PTSD; Setbacks and New Directions Womble Bond Dickinson (US) LLP
Sep
10
2024
 FSIS Updates Guidance for Animal-Raising and Environmental Claims Keller and Heckman LLP
Sep
10
2024
 BIOSECURE Act: Anticipated Movement, Key Provisions, and Likely Impact Foley & Lardner LLP
Sep
9
2024
 Challenges in AI-Enabled Biomarker Discovery Foley & Lardner LLP
Sep
9
2024
 Alabama Court Signals Possible Willingness to Allow Medical Program to Move Forward in Part Bradley Arant Boult Cummings LLP
Sep
9
2024
 China Expands Pilot Program for Foreign Investment in the Healthcare Sector Sheppard, Mullin, Richter & Hampton LLP
Sep
6
2024
 Dos and Don’ts for Advertising, Packaging and Labeling of Cannabis Products in Illinois Sheppard, Mullin, Richter & Hampton LLP
Sep
6
2024
 DEA Will Hold Public Hearing to Address Marijuana Rescheduling Jackson Lewis P.C.
Sep
6
2024
 Seasonal Considerations for Packaging and Selling Alcoholic Beverages McDermott Will & Emery
Sep
6
2024
 DOD Announces Seven Awards via the Distributed Bioindustrial Manufacturing Program Bergeson & Campbell, P.C.
Sep
6
2024
 McDermott+ Check-Up: September 6, 2024 McDermott Will & Emery
Sep
6
2024
 Obtaining Clearances Through FDA's Food Contact Notification Program K&L Gates LLP
Sep
6
2024
 Federal Court Permits Investors to Resume Kickback Suit Against Teva ArentFox Schiff LLP
Sep
6
2024
 FDA Publishes FY2022 Pesticide Residue Monitoring Program Report Keller and Heckman LLP
Sep
6
2024
 House Subcommittee Will Hold Legislative Hearing on Evaluating FDA Human Foods and Tobacco Programs Bergeson & Campbell, P.C.
Sep
6
2024
 HHS-OIG Declines Sanctions on Diabetes Patient Program Subsidizing Medicare Cost-Sharing Barnes & Thornburg LLP
Sep
6
2024
 Plaintiff’s Attorney Spencer Sheehan Sanctioned Keller and Heckman LLP
Sep
6
2024
 Looking For a Drink At 3 A.M.? Soon, You May Find One Here Allen Matkins Leck Gamble Mallory & Natsis LLP
Sep
5
2024
 Class Action Litigation Newsletter | 2nd Quarter 2024 Greenberg Traurig, LLP
Sep
5
2024
 George Washington’s Whisky Distillery, 21st Century Edition Bradley Arant Boult Cummings LLP
Sep
5
2024
 USPTO Issues Updated AI Subject Matter Eligibility Guidance ArentFox Schiff LLP
Sep
5
2024
 China Calls for Submissions of New Health Claims Keller and Heckman LLP
Sep
5
2024
 BETO Calls for Feedstock-Conversion Interface Consortium Industry Partnerships Bergeson & Campbell, P.C.
Sep
4
2024
 Attorney’s Fees May Be Recoverable in Trade Secret Cases, Even Without Damages Sheppard, Mullin, Richter & Hampton LLP
Sep
4
2024
 FDA Continues to Intentionally Incorporate AI into Medical Product Development with Its Establishment of a New Internal Advisory Body Mintz
Displaying 253 - 280 of 11741
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins